These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
94 related articles for article (PubMed ID: 2805409)
1. Occurrence of platelet-activating factor (PAF) and an endogenous inhibitor of platelet aggregation in diffuse cutaneous mastocytosis. Macpherson JL; Kemp A; Rogers M; Mallet AI; Toia RF; Spur B; Earl JW; Chesterman CN; Krilis SA Clin Exp Immunol; 1989 Sep; 77(3):391-6. PubMed ID: 2805409 [TBL] [Abstract][Full Text] [Related]
2. Characterization of cutaneous vascular permeability induced by platelet-activating factor in guinea pigs and rats and its inhibition by a platelet-activating factor receptor antagonist. Hwang SB; Li CL; Lam MH; Shen TY Lab Invest; 1985 Jun; 52(6):617-30. PubMed ID: 3925239 [TBL] [Abstract][Full Text] [Related]
3. Platelet-activating factor: mediator of the third pathway of platelet aggregation? A study in three patients with deficient platelet-activating factor synthesis. Sturk A; Schaap MC; ten Cate JW; Heymans HS; Schutgens RB; Przyrembel H; Borst P J Clin Invest; 1987 Feb; 79(2):344-50. PubMed ID: 3805272 [TBL] [Abstract][Full Text] [Related]
4. Cutaneous mastocytosis: a case of bullous urticaria pigmentosa. Vasili E; Savo I; Doci X; Shkodrani E; Ntemoy A Cutis; 2013 Feb; 91(2):70-2. PubMed ID: 23513553 [TBL] [Abstract][Full Text] [Related]
5. Effects of tetrandrine on rabbit platelet aggregation and platelet activating factor generation. Zhang M; Zhang LZ; Lu JS Zhongguo Yao Li Xue Bao; 1995 May; 16(3):209-12. PubMed ID: 7660812 [TBL] [Abstract][Full Text] [Related]
6. Receptor-mediated and protein kinase-dependent growth enhancement of primary human fibroblasts by platelet activating factor. Bennett SA; Birnboim HC Mol Carcinog; 1997 Dec; 20(4):366-75. PubMed ID: 9433481 [TBL] [Abstract][Full Text] [Related]
8. Rupatadine, a new potent, orally active dual antagonist of histamine and platelet-activating factor (PAF). Merlos M; Giral M; Balsa D; Ferrando R; Queralt M; Puigdemont A; García-Rafanell J; Forn J J Pharmacol Exp Ther; 1997 Jan; 280(1):114-21. PubMed ID: 8996188 [TBL] [Abstract][Full Text] [Related]
9. Biochemical evidence of platelet-activating factor (PAF) in human middle ear effusions. Furukawa M; Kubo N; Yamashita T Laryngoscope; 1995 Feb; 105(2):188-91. PubMed ID: 8544602 [TBL] [Abstract][Full Text] [Related]
10. [Diffuse skin mastocytosis of nurslings. 3 clinical cases with bullous manifestations]. Stewart WM; Lauret P; Thomine ME; Leroy D; Boullié MC Ann Dermatol Syphiligr (Paris); 1976; 103(4):393-402. PubMed ID: 1020927 [TBL] [Abstract][Full Text] [Related]
11. Calcium-dependent synergistic interaction of platelet activating factor and epinephrine in human platelet aggregation. Saeed SA; Rasheed H Acta Pharmacol Sin; 2003 Jan; 24(1):31-6. PubMed ID: 12511226 [TBL] [Abstract][Full Text] [Related]
12. Platelet-activating factor and anti-platelet-aggregating factor in acute reduction of blood pressure following percutaneous transluminal renal angioplasty in patients with renovascular hypertension. Masugi F; Ogihara T; Saeki S; Sakaguchi K; Kumahara Y J Hum Hypertens; 1988 Aug; 2(2):111-6. PubMed ID: 2977405 [TBL] [Abstract][Full Text] [Related]
13. The existence of a platelet-activating factor (Paf-acether)-like substance in blister fluid derived from patients with bullous pemphigoid as demonstrated by human platelet aggregation techniques. Okubo K; Karashima T; Hachisuka H; Sasai Y Kurume Med J; 1989; 36(4):173-9. PubMed ID: 2700767 [TBL] [Abstract][Full Text] [Related]
14. Isolation and identification of hydroxyl-platelet-activating factor from natural sources. Tsoupras AB; Antonopoulou S; Baltas G; Samiotaki M; Panayotou G; Kotsifaki H; Mantzavinos Z; Demopoulos CA Life Sci; 2006 Oct; 79(19):1796-803. PubMed ID: 16860827 [TBL] [Abstract][Full Text] [Related]
15. Hydroxyl-platelet-activating factor exists in blood of healthy volunteers and periodontal patients. Antonopoulou S; Tsoupras A; Baltas G; Kotsifaki H; Mantzavinos Z; Demopoulos CA Mediators Inflamm; 2003 Aug; 12(4):221-7. PubMed ID: 14514473 [TBL] [Abstract][Full Text] [Related]
16. Inhibitory effect of the Korean herbal medicine, Dae-Jo-Whan, on platelet-activating factor-induced platelet aggregation. Chang GT; Kang SK; Kim JH; Chung KH; Chang YC; Kim CH J Ethnopharmacol; 2005 Dec; 102(3):430-9. PubMed ID: 16125889 [TBL] [Abstract][Full Text] [Related]
17. Presence of platelet-activating factor in squirrel monkey (Saimiri boliviensis) spermatozoa: seasonal differences. Roudebush WE; Mathur RS Am J Primatol; 1998; 45(3):301-5. PubMed ID: 9651652 [TBL] [Abstract][Full Text] [Related]
18. Amifostine, a reactive oxigen species scavenger with radiation- and chemo-protective properties, inhibits in vitro platelet activation induced by ADP, collagen or PAF. Porta C; Maiolo A; Tua A; Grignani G Haematologica; 2000 Aug; 85(8):820-5. PubMed ID: 10942928 [TBL] [Abstract][Full Text] [Related]
19. Antigen-initiated release of platelet-activating factor (PAF-acether) from mouse bone marrow-derived mast cells sensitized with monoclonal IgE. Mencia-Huerta JM; Lewis RA; Razin E; Austen KF J Immunol; 1983 Dec; 131(6):2958-64. PubMed ID: 6315819 [TBL] [Abstract][Full Text] [Related]
20. High affinity specific binding sites for tritiated platelet-activating factor in canine platelet membranes: counterparts of platelet-activating factor receptors mediating platelet aggregation. Tahraoui L; Floch A; Mondot S; Cavero I Mol Pharmacol; 1988 Aug; 34(2):145-51. PubMed ID: 2842653 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]